Latest News
Union Agriculture Minister Shivraj Singh Chouhan will dedicate India's first indigenous inactivated H5N1 (Clade 2.3.2.1a) bird flu vaccine for chickens to the nation on 20 November 2026 at ICAR-NIHSAD, Bhopal, which developed it.
Why is it in the news?
- The Ministry of Agriculture and Farmers Welfare said on 18 November 2026 that the vaccine will be dedicated to the nation on 20 November 2026 at ICAR-NIHSAD, Bhopal.
- ICAR-NIHSAD developed it: the first home-grown killed-virus vaccine for chickens against the H5N1 bird flu strain of Clade 2.3.2.1a.
- At present no specific commercial vaccine exists against this Clade 2.3.2.1a strain.
What is the background?
Highly Pathogenic Avian Influenza (HPAI), or bird flu, is a grave poultry disease. Infected flocks can die almost entirely, and culling and trade curbs cause heavy losses.
After the first case in India in 2006, over 500 outbreaks of the H5N1 and H5N8 subtypes together have been recorded. The 2006 outbreak cost an estimated Rs. 2,200–3,000 crore in direct and indirect losses.
Most chicken outbreaks have been linked to Clade 2.3.2.1a. It has also turned up in other animals, including mammals, and in three human cases.
Quick recap for revision
A major outbreak could cut India's GDP growth by up to 1.5 per cent, and over 20 per cent of the poultry population is at risk if spread goes unchecked. In Manipur an outbreak cost the state 0.5 per cent of its GDP. The new vaccine targets the Clade 2.3.2.1a strains now circulating, to protect farmers' incomes and stop spread from chickens to other animals and people.
Key facts at a glance
| Indicator | Figure |
|---|---|
| Developer | ICAR-NIHSAD, Bhopal |
| Vaccine type | Inactivated H5N1 (Clade 2.3.2.1a), for chickens |
| Dedication date | 20 November 2026 |
| Outbreaks since 2006 | More than 500 (H5N1 and H5N8) |
| Estimated loss, 2006 outbreak | Rs. 2,200–3,000 crore |
| Poultry at risk if uncontrolled | More than 20 per cent |
| WHO human cases since 2003 | 1,003 cases, 479 deaths, 25 countries |
Static link: what to connect it with
- Animal disease control links to GS-III agriculture and livestock, and to science and technology through indigenous vaccine development.
- ICAR-NIHSAD is the national institute for high security animal diseases, a body of the Indian Council of Agricultural Research.
- Bird flu is also a public health concern, the zoonotic link between animal and human health.
- Related reading: Prelims current affairs.
Uttar Pradesh angle
Uttar Pradesh poultry numbers and department roles for this vaccine are awaited from state sources, so no state figure is given. For GS-VI, the link is general: poultry disease control and farmers' livelihoods matter in every state, and aspirants should use official Uttar Pradesh animal husbandry sources for state-level poultry numbers and outbreak history.
Likely confusions
- H5N1 is not H5N8: the release counts more than 500 combined outbreaks of the two subtypes since 2006.
- The vaccine is inactivated and is for chickens; it is not a human vaccine.
- The dedication date is 20 November 2026, while the press release is dated 18 November 2026.
Key Terms
- HPAI
- Highly Pathogenic Avian Influenza, commonly called bird flu.
- Clade 2.3.2.1a
- The H5N1 strain responsible for most bird flu outbreaks in chickens.
- ICAR-NIHSAD
- ICAR National Institute of High Security Animal Diseases, Bhopal.
- Inactivated vaccine
- A vaccine made from killed virus.
- Culling
- Killing of infected or exposed birds to stop spread.
UPPSC syllabus: GS-III, GS-VI
FAQs
Who developed the vaccine?
ICAR-NIHSAD, Bhopal.
When will it be dedicated to the nation?
On 20 November 2026, at ICAR-NIHSAD, Bhopal.
Is it a human vaccine?
No. It is an inactivated vaccine for chickens.
Last verified: 2026-11-19